Jiva Technologies Announces Debt Settlements
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC, July 8,...
Month: July 2025
BTCS Inc. Announces Intent to Raise $100 Million for Strategic Ethereum Acquisition Using DeFi/TradFi Flywheel
Silver Spring, MD, July 08, 2025 (GLOBE NEWSWIRE) -- BTCS Inc. (Nasdaq: BTCS) (“BTCS” or the “Company”) short for Blockchain...
Ten Trades to Watch July 8, 2025
DENVER, Colo., Jul 08, 2025 (247marketnews.com)- ProKidney (NASDAQ:PROK) surged after reporting statistically significant and clinically meaningful topline results from the...
Don’t Miss Out: MoBot’s Latest Stock Updates 07/08/25 09:00 AM
DENVER, Colo., 07/08/25 09:00 AM (247marketnews.com) – (NASDAQ: MBRX, NASDAQ: UONEK, NYSE: SRFM, NASDAQ: WKHS, NYSE: KULR) are discussed in...
Longeveron® Announces U.S. FDA Approval of IND Application for a Phase 2 Pivotal Registration Study Evaluating Laromestrocel as a Treatment of Pediatric Dilated Cardiomyopathy (DCM)
Accepted IND application allows for development program to move directly to a Phase 2 pivotal registration clinical trialPhase 2 clinical...
KULR Technology Group Announces $20 Million Credit Facility with Coinbase
HOUSTON, July 08, 2025 (GLOBE NEWSWIRE) -- KULR Technology Group, Inc. (NYSE American: KULR) (the "Company" or "KULR"), a Bitcoin...
24/7 Market News Snapshot 08 July, 2025 – KULR Technology Group, Inc. (NYSE:KULR)
DENVER, Colo., 08 July, 2025 (www.247marketnews.com) – (NYSE:KULR) are discussed in this article. KULR Technology Group, Inc. (NYSE American: KULR),...
24/7 Market News Snapshot 08 July, 2025 – BTCS Inc. Common Stock (NASDAQ:BTCS)
DENVER, Colo., 08 July, 2025 (www.247marketnews.com) – (NASDAQ:BTCS) are discussed in this article. BTCS Inc. (Nasdaq: BTCS) has demonstrated substantial...
Humacyte announces Symvess™ ECAT Approval from U.S. Defense Logistics Agency
DURHAM, N.C., July 08, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable,...
24/7 Market News Snapshot 08 July, 2025 – Humacyte, Inc. Common Stock (NASDAQ:HUMA)
DENVER, Colo., 08 July, 2025 (www.247marketnews.com) – (NASDAQ:HUMA) are discussed in this article. Humacyte, Inc. is experiencing significant momentum in...
CENTURY LITHIUM COMMENDS FIRST PHOSPHATE IN MAKING LFP BATTERY CELLS USING CENTURY LITHIUM MATERIAL
VANCOUVER, BC, July 8, 2025 /PRNewswire/ - Century Lithium Corp. (TSXV: LCE) (OTCQX: CYDVF) (Frankfurt: C1Z) ("Century Lithium" or "the Company")...
Syra Health Earns ISO 27001:2022 Certification, Highlighting Company’s Commitment to Data Protection
CARMEL, Ind., July 8, 2025 /PRNewswire/ -- Syra Health (OTCQB: SYRA), a healthcare technology company dedicated to powering better health...
Stagwell (STGW) Advances Executive Team with Four Key Appointments
NEW YORK, July 8, 2025 /PRNewswire/ -- Stagwell (NASDAQ: STGW), the challenger network built to transform marketing, today announced the appointments of...
24/7 Market News Snapshot 08 July, 2025 – Longeveron Inc. Common Stock (NASDAQ:LGVN)
DENVER, Colo., 08 July, 2025 (www.247marketnews.com) – (NASDAQ:LGVN) are discussed in this article. Longeveron Inc. (LGVN) is experiencing a significant...
CENTURY LITHIUM COMMENDS FIRST PHOSPHATE IN MAKING LFP BATTERY CELLS USING CENTURY LITHIUM MATERIAL
VANCOUVER, BC, July 8, 2025 /PRNewswire/ - Century Lithium Corp. (TSXV: LCE) (OTCQX: CYDVF) (Frankfurt: C1Z) ("Century Lithium" or "the Company")...
Citius Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement
CRANFORD, N.J. , July 8, 2025 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius Pharma" or the "Company") (Nasdaq: CTXR) today announced...
Rallybio Sells Interest in REV102 Program to Recursion Pharmaceuticals
NEW HAVEN, Conn.--(BUSINESS WIRE)--Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with...
Plus Therapeutics Announces Initial Patients Successfully Treated in ReSPECT-LM Dose Optimization Trial for REYOBIQ™ in Leptomeningeal Metastases
HOUSTON, July 08, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted...
BTC Digital Ltd. Announces Major Milestone on Georgia 20 MW Mining Project and Introduces Advanced Liquid-Cooling Technology for the First Time
SINGAPORE, July 8, 2025 /PRNewswire/ -- BTC Digital Ltd. ("BTCT" or the "Company") (NASDAQ: BTCT), a leading blockchain technology company, today...
Oncolytics Biotech® Highlights Transformative Pelareorep Survival Data in Multiple Tumors and Commitment to Registration-Enabling Studies
Comparison with multiple landmark first-line metastatic pancreatic ductal adenocarcinoma studies substantiates strong two-year survival benefit of 21.9% vs. 9.2% historical...
Don’t Miss Out: MoBot’s Latest Stock Updates 07/08/25 08:00 AM
DENVER, Colo., 07/08/25 08:00 AM (247marketnews.com) – (NASDAQ: PSTV, NASDAQ: RLYB, NYSE: WOLF, NASDAQ: ZVSA, NASDAQ: VIOT) are discussed in...
ZyVersa Backs FDA-Authorized Emergency Compassionate Use of Cholesterol Efflux Mediator VAR 200 in Patient with ApoCII Amyloidosis
DENVER, Colo., Jul 08, 2025 (247marketnews.com)- ZyVersa (NASDAQ:ZVSA) announced its support for the FDA-authorized Emergency Compassionate Use of its investigational...
24/7 Market News Snapshot 08 July, 2025 – PLUS THERAPEUTICS, Inc. Common Stock (NASDAQ:PSTV)
DENVER, Colo., 08 July, 2025 (www.247marketnews.com) – (NASDAQ:PSTV) are discussed in this article. Plus Therapeutics, Inc. (Nasdaq: PSTV) is experiencing...
ZyVersa Therapeutics Supports FDA-Authorized Emergency Compassionate Use of Cholesterol Efflux Mediator™ VAR 200 in a Patient with ApoCII Amyloidosis
ApoCII amyloidosis, resulting from abnormal organ deposition of toxic fibrillar amyloid proteins, is an ultra-rare condition that mostly affects the...
i-80 Gold Provides Progress Update on its New Development Plan
RENO, Nev., July 8, 2025 /PRNewswire/ - i-80 GOLD CORP. (TSX: IAU) (NYSE American: IAUX) ("i-80" or the "Company") is pleased...
24/7 Market News Snapshot 08 July, 2025 – Rallybio Corporation Common Stock (NASDAQ:RLYB)
DENVER, Colo., 08 July, 2025 (www.247marketnews.com) – (NASDAQ:RLYB) are discussed in this article. Rallybio Corporation (RLYB) has garnered attention in...
Harmonic Sets DOCSIS 4.0 Record with 14 Gbps Downstream Speed at CableLabs Interoperability Event
SAN JOSE, Calif., July 8, 2025 /PRNewswire/ -- Harmonic (NASDAQ: HLIT) today announced a record-breaking demonstration at the recent CableLabs®...
Garmin smartwatches add turn-by-turn directions with Google Maps
Google Maps app arrives to the Connect IQ Store, providing directions on the wristOLATHE, Kan., July 8, 2025 /PRNewswire/ --...
Evogene Announces Completion of Transaction for the Sale of Lavie Bio’s Activity to ICL
REHOVOT, Israel, July 8, 2025 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company utilizing cutting-edge artificial...
SolarBank’s 7.2 MW Hoadley Hill Project Successfully Completes Major Interconnection Study on Path to Permit
Project to Power Equivalent of 850 Homes TORONTO, July 8, 2025 /PRNewswire/ - SolarBank Corporation (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE:...
Soligenix Corporate Update Letter – Key Highlights and Upcoming Milestones
PRINCETON, N.J., July 8, 2025 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused...
Cryoport’s MVE Biological Solutions Introduces Next Generation Vapor Shippers
New SC vapor shipper series improves reliability through extended hold times and patented impact-absorbing and Vapor Shield Technology NASHVILLE, Tenn.,...
CARGO Therapeutics Enters into Agreement to Be Acquired by Concentra Biosciences for $4.379 in Cash per Share Plus a Contingent Value Right
SAN CARLOS, Calif., July 08, 2025 (GLOBE NEWSWIRE) -- CARGO Therapeutics, Inc. (“CARGO” or the “Company”) (NASDAQ: CRGX), a biotechnology...
ProKidney Reports Statistically and Clinically Significant Topline Results for the Phase 2 REGEN-007 Trial Evaluating Rilparencel in Patients with Chronic Kidney Disease and Diabetes
Full results from REGEN-007 are being held and will be submitted to the American Society of Nephrology 2025 Kidney Week...
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America
LAS VEGAS, July 8, 2025 /PRNewswire/ -- Avant Technologies, Inc. (OTCQB: AVAI) ("Avant" or the "Company"), and its JV partner,...
NUTEX HEALTH HOSPITALS’ 2025 Q2 AWARDS
HOUSTON, July 8, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare...
24/7 Market News Snapshot 08 July, 2025 – ZyVersa Therapeutics, Inc. Common Stock (NASDAQ:ZVSA)
DENVER, Colo., 08 July, 2025 (www.247marketnews.com) – (NASDAQ:ZVSA) are discussed in this article. ZyVersa Therapeutics, Inc. (ZVSA) is experiencing a...
MoBot’s Stock Market Highlights – 07/08/25 07:00 AM
DENVER, Colo., 07/08/25 07:00 AM (247marketnews.com) – (NASDAQ: ZVSA, NASDAQ: NDRA, NASDAQ: LSB, NASDAQ: PROK, NASDAQ: LTRN) are discussed in...
ProKidney Reports Positive Phase 2 REGEN-007 Trial Topline Results
DENVER, Colo., Jul 08, 2025 (247marketnews.com)- ProKidney (NASDAQ:PROK) reported positive topline results from the Group 1 modified intent-to-treat (mITT) population...
Sequans to Launch Bitcoin Treasury Initiative with $384M Strategic Investment
DENVER, Colo., Jul 08, 2025 (247marketnews.com)- Sequans Communications (NYSE:SQNS) secured a total of $384 million in capital to implement the...